Published in Gene on October 11, 1994
A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol Immunol (2009) 1.16
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc Natl Acad Sci U S A (1996) 1.12
Binding to DPF-motif by the POB1 EH domain is responsible for POB1-Eps15 interaction. BMC Biochem (2007) 0.87
Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold. Front Microbiol (2015) 0.81
Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J Virol (1997) 0.80
pEMBL: a new family of single stranded plasmids. Nucleic Acids Res (1983) 19.19
Novel bacteriophage lambda cloning vector. Proc Natl Acad Sci U S A (1980) 8.97
Plasmids pEMBLY: new single-stranded shuttle vectors for the recovery and analysis of yeast DNA sequences. Gene (1985) 5.73
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro. Nucleic Acids Res (1983) 4.14
The yeast homologue of U3 snRNA. EMBO J (1987) 3.74
The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell (1989) 3.51
Two different liver-specific factors stimulate in vitro transcription from the human alpha 1-antitrypsin promoter. EMBO J (1988) 3.14
Base pairing of RNA I with its complementary sequence in the primer precursor inhibits ColE1 replication. Nature (1981) 3.11
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature (1991) 3.10
Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module. Genes Dev (1997) 3.01
Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem (2001) 2.93
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Expression and immunological properties of the five subunits of pertussis toxin. Infect Immun (1987) 2.59
Control of ColE1 DNA replication: the rop gene product negatively affects transcription from the replication primer promoter. Proc Natl Acad Sci U S A (1982) 2.56
The most abundant small cytoplasmic RNA of Saccharomyces cerevisiae has an important function required for normal cell growth. Mol Cell Biol (1989) 2.55
A model for the hepatitis C virus envelope glycoprotein E2. Proteins (2000) 2.17
Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains. J Biol Chem (1998) 2.13
A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell (1990) 2.09
A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1 beta in Saccharomyces cerevisiae. EMBO J (1987) 2.05
Promoter of the pertussis toxin operon and production of pertussis toxin. J Bacteriol (1987) 1.98
Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol (1991) 1.90
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J (1994) 1.90
A relationship between replicon size and supercoiled loop domains in the eukaryotic genome. Nature (1982) 1.80
Identification of the ferroxidase centre in ferritin. FEBS Lett (1989) 1.78
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol (2000) 1.70
Design and properties of a Myc derivative that efficiently homodimerizes. Oncogene (1998) 1.69
SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family. J Mol Biol (2000) 1.67
Antagonistic controls regulate copy number of the yeast 2 mu plasmid. EMBO J (1987) 1.66
Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J (1990) 1.63
A novel peptide-SH3 interaction. EMBO J (1999) 1.61
LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J (1991) 1.60
Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc Natl Acad Sci U S A (1998) 1.56
SnR30: a new, essential small nuclear RNA from Saccharomyces cerevisiae. Nucleic Acids Res (1988) 1.48
Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene (1993) 1.47
Physical and functional interaction between p53 mutants and different isoforms of p73. J Biol Chem (2000) 1.43
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut (2004) 1.42
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy. Vaccine (2009) 1.41
High-level expression of RNAs and proteins: the use of oligonucleotides for the precise fusion of coding-to-regulatory sequences. Gene (1985) 1.38
Recognition specificity of individual EH domains of mammals and yeast. EMBO J (1998) 1.36
The X-ray structure of an atypical homeodomain present in the rat liver transcription factor LFB1/HNF1 and implications for DNA binding. EMBO J (1993) 1.32
Interaction between RNA1 and the primer precursor in the regulation of Co1E1 replication. J Mol Biol (1983) 1.32
Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J Immunol (1995) 1.32
Modifying filamentous phage capsid: limits in the size of the major capsid protein. J Mol Biol (1995) 1.31
The Salmonella wien virulence plasmid pZM3 carries Tn1935, a multiresistance transposon containing a composite IS1936-kanamycin resistance element. Plasmid (1988) 1.30
Phasmids: hybrids between ColE1 plasmids and E. coli bacteriophage lambda. Gene (1982) 1.28
Functional analysis of the yeast plasmid partition locus STB. EMBO J (1986) 1.28
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years. J Viral Hepat (2006) 1.26
ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation (1997) 1.26
A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene (1996) 1.26
Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol (1994) 1.25
Recombinant H-chain ferritins: effects of changes in the 3-fold channels. FEBS Lett (1989) 1.24
The SH3 domains of endophilin and amphiphysin bind to the proline-rich region of synaptojanin 1 at distinct sites that display an unconventional binding specificity. J Biol Chem (1999) 1.24
Mutational analysis of the channel and loop sequences of human ferritin H-chain. Biochem J (1989) 1.19
A role for H-NS in the regulation of the virF gene of Shigella and enteroinvasive Escherichia coli. Res Microbiol (1998) 1.19
Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut (2006) 1.19
Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines. Semin Liver Dis (2000) 1.18
The efficiency of walking of paraplegic patients using a reciprocating gait orthosis. Paraplegia (1995) 1.16
Control of initiation of pMB1 replication: purified Rop protein and RNA I affect primer formation in vitro. Cell (1984) 1.16
The RNA primer promoter, as defined in vitro, is essential for pMB1 plasmid replication in vivo. J Mol Biol (1982) 1.15
Cost of walking and locomotor impairment. J Electromyogr Kinesiol (1999) 1.15
Subunit interactions provide a significant contribution to the stability of the dimeric four-alpha-helical-bundle protein ROP. Biochemistry (1993) 1.14
Linking an easily detectable phenotype to the folding of a common structural motif. Selection of rare turn mutations that prevent the folding of Rop. J Mol Biol (1994) 1.14
Protein plasticity to the extreme: changing the topology of a 4-alpha-helical bundle with a single amino acid substitution. Structure (1999) 1.14
Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol (2000) 1.13
Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? Antiviral Res (2001) 1.13
Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotechnol (1996) 1.12
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc Natl Acad Sci U S A (1996) 1.12
Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene (1994) 1.08